Options for Therapeutic Abortion or Early Pregnancy Loss:
MVA and Medication Management

Scroll down for a link to the archived sessions

Web Faculty Bio

• Jini Tanenhaus, PA-C, MA: She is past president of the Association of PA’s in OB-GYN. She has served the American Academy of Physician Assistants as liaison to the American College of Obstetricians and Gynecologists (ACOG) and currently serves as the first PA on the board of directors of the Association of Reproductive Health Professionals (ARHP). She is a frequent lecturer on Reproductive Health topics.

Accreditation Information

The Association of Reproductive Health Professionals is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. ARHP designates this continuing medical education activity for 1 credit hour in Category 1 of the Physician's Recognition Award of the American Medical Association. This educational activity has been approved by the Continuing Education Approval Program of the National Association of Nurse Practitioners in Women's Health for 1.0 contact hour, including 0.75 pharmacology hours. Credit can be applied toward the nursing continuing requirements of most professional organizations and State Boards of Nursing.

Sponsoring Information

This program is sponsored by the Association of Reproductive Health Professionals.

Funding Information

The project and webinar have been made possible through an unrestricted educational grant from Ipas.

Disclosure Information

All individuals in a position to influence the content of this activity must disclose relevant financial relationship(s) with commercial interests and the nature of the relationship. A commercial interest is defined as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients.

Web Faculty Disclosure

• Jini Tanenhaus, PA-C, MA: has no affiliations to disclose

Advisory Committee Disclosures

• Herbert P. Brown, MD: has no affiliations to disclose
• Michelle Forcier, MD, MPH: Consultant for Planned Parenthood Chicago Area; stock/shareholder for Pfizer; speaker for Merck and Ipas
• Emily Godfrey, MD, MPH: Speaker for Organon Pharmaceuticals and Merck
• Marji Gold, MD: has no affiliations to disclose
• Jini Tanenhaus, PA-C, MA: has no affiliations to disclose

ARHP Staff/Consultant Disclosures

• Shama Alam, MScPH, Diane Shannon, MD, MPH, Wayne Shields, Amy Swann, MA, and Allison Tombros, MHS have no affiliations to disclose

Click here to view archived session